The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 23, Issue 1, Pages 59-69
Publisher
Springer Nature
Online
2017-10-03
DOI
10.1038/mp.2017.190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders
- (2017) C A Zarate et al. MOLECULAR PSYCHIATRY
- Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine
- (2017) Abhishekh H. Ashok et al. JAMA Psychiatry
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The effects of Δ9-tetrahydrocannabinol on the dopamine system
- (2016) Michael A. P. Bloomfield et al. NATURE
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Reward Processing and Risk for Depression Across Development
- (2016) Katherine R. Luking et al. TRENDS IN COGNITIVE SCIENCES
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia
- (2015) Ke Xu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons
- (2015) Kareem S El Iskandrani et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
- (2015) Charles F. Zorumski et al. Frontiers in Psychiatry
- Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity
- (2014) Pauline Belujon et al. BIOLOGICAL PSYCHIATRY
- Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex
- (2013) Y. Usun et al. BEHAVIOURAL BRAIN RESEARCH
- Subanesthetic Doses of Ketamine Transiently Decrease Serotonin Transporter Activity: A PET Study in Conscious Monkeys
- (2013) Shigeyuki Yamamoto et al. NEUROPSYCHOPHARMACOLOGY
- Combinational effects of ketamine and amphetamine on behaviors and neurotransmitter systems of mice
- (2013) Chuan-Ching Lai et al. NEUROTOXICOLOGY
- Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users
- (2013) James M. Stone et al. PSYCHOPHARMACOLOGY
- Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability
- (2012) Ingo Vernaleken et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology
- (2012) J M Stone et al. MOLECULAR PSYCHIATRY
- Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice
- (2012) Manavi Chatterjee et al. NEUROPHARMACOLOGY
- Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
- (2012) Romina Mizrahi et al. NEUROPSYCHOPHARMACOLOGY
- Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice
- (2012) Sijie Tan et al. PLoS One
- Ketamine use: a review
- (2011) Celia J. A. Morgan et al. ADDICTION
- Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
- (2011) Oliver D. Howes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans
- (2011) Paul Shotbolt et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
- (2011) O Howes et al. MOLECULAR PSYCHIATRY
- In vivoandex vivoevidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia
- (2011) Sang-Young Kim et al. NMR IN BIOMEDICINE
- The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses
- (2010) S. Sorce et al. JOURNAL OF NEUROSCIENCE
- Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway
- (2010) H. Kamiyama et al. NEUROSCIENCE
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
- (2009) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- The dopaminergic basis of human behaviors: A review of molecular imaging studies
- (2009) Alice Egerton et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine
- (2007) Jing-Jer Ke et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More